Plasmodium infection
Showing 1 - 25 of >10,000
Severe Malaria, Uncomplicated Malaria, Asyptomatic Plasmodium Infection Trial
Not yet recruiting
- Severe Malaria
- +2 more
- (no location specified)
Oct 6, 2023
Malaria Infection Trial in Darmstadt (M5717 60 mg, Pyronaridine, Atovaquone-Proguanil)
Not yet recruiting
- Malaria Infection
- M5717 60 mg
- +4 more
-
Darmstadt, GermanyResearch Site
Aug 2, 2023
Malaria Trial run by the NIAID (HMPBS02-Pv)
Active, not recruiting
- Malaria
- HMPBS02-Pv
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 5, 2022
Malaria, Vivax Trial in Oxford (Plasmodium vivax infection, Collection of 250mL blood from each volunteer (N=2))
Active, not recruiting
- Malaria, Vivax
- Plasmodium vivax infection
- Collection of 250mL blood from each volunteer (N=2)
-
Oxford, Oxfordshire, United Kingdom
- +1 more
Apr 27, 2022
Malaria, Plasmodium Falciparum Trial in Bagamoyo (P. falciparum infected erythrocytes)
Not yet recruiting
- Malaria
- Plasmodium Falciparum
- P. falciparum infected erythrocytes
-
Bagamoyo, TanzaniaIfakara Health Institute
May 26, 2022
Plasmodium Vivax Infection Trial in Bangkok (Mosquito bites)
Recruiting
- Plasmodium Vivax Infection
- Mosquito bites
-
Bangkok, ThailandFaculty of Tropical Medicine
Jun 6, 2022
Plasmodium Vivax Infection, Malaria Vaccine Trial in Bangkok (Malaria Vaccine, HBV vaccine)
Not yet recruiting
- Plasmodium Vivax Infection
- Malaria Vaccine
- Malaria Vaccine
- HBV vaccine
-
Bangkok, ThailandFaculty of Tropical Medicine
Jan 16, 2023
Plasmodium Falciparum Infection, Malaria Trial in Faladje, Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal Saline)
Not yet recruiting
- Plasmodium Falciparum Infection
- Malaria
- L9LS (VRC-MALMAB0114-00-AB)
- Normal Saline
-
Faladje, Région De Koulikoro, Mali
- +2 more
Apr 17, 2023
Malaria,Falciparum, Plasmodium Falciparum, Plasmodium Berghei Trial in Nijmegen, Rotterdam (Pb(PfCS@UIS4)-infected mosquitoes,
Completed
- Malaria,Falciparum
- +3 more
- Pb(PfCS@UIS4)-infected mosquitoes
- Challenge infection P. falciparum
-
Nijmegen, Gelderland, Netherlands
- +1 more
Feb 23, 2022
Plasmodium Falciparum Infection, Malaria Trial in Kisumu (L9LS, Normal Saline)
Recruiting
- Plasmodium Falciparum Infection
- Malaria
- L9LS
- Normal Saline
-
Kisumu, KenyaKenya Medical Research Institute (KEMRI) Center for Global Healt
Sep 15, 2022
Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (VRC-MALMAB0100-00-AB (CIS43LS), Normal saline)
Active, not recruiting
- Plasmodium Falciparum Infection
- Malaria
- VRC-MALMAB0100-00-AB (CIS43LS)
- Normal saline
-
Kalifabougou, Région De Koulikoro, Mali
- +1 more
Sep 20, 2022
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
Plasmodium Vivax Infection Trial in Bangkok (An inoculum of malaria parasitised red blood cells with whole dose blood-stage
Recruiting
- Plasmodium Vivax Infection
- An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum
- +3 more
-
Bangkok, ThailandFaculty of Tropical Medicine
Jun 21, 2022
Malaria Trial in Bamako (Chloroquine Phosphate, PfSPZ Challenge, Pyrimethamine)
Completed
- Malaria
- Chloroquine Phosphate
- +4 more
-
Bamako, MaliMalaria Vaccine Center STTB/MRTC
Jun 21, 2022
Malaria,Falciparum Trial in Kilifi (PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine)
Not yet recruiting
- Malaria,Falciparum
- PfSPZ Challenge
- +4 more
-
Kilifi, KenyaKEMRI-Wellcome Trust Research Programme
May 17, 2022
Healthy Trial in Seattle (DSM265, Placebo, Sporozoites)
Completed
- Healthy
- DSM265
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center - Prevention Center
Jan 13, 2022
Plasmodium Infection Trial (Personal protection package)
Not yet recruiting
- Plasmodium Infection
- Personal protection package
- (no location specified)
Nov 2, 2021
Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal saline)
Recruiting
- Plasmodium Falciparum Infection
- Malaria
- L9LS (VRC-MALMAB0114-00-AB)
- Normal saline
-
Kalifabougou, Région De Koulikoro, Mali
- +1 more
Apr 7, 2022
Malaria, Malaria,Falciparum Trial in Baltimore (PfSPZ Vaccine, PfSPZ Challenge (7G8), Normal Saline)
Recruiting
- Malaria
- Malaria,Falciparum
- PfSPZ Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Nov 2, 2022
Plasmodium Malariae Infection, SMC, Immune System Disease Trial in Parakou (saisonal malaria chimoprevention)
Completed
- Plasmodium Malariae Infection
- +2 more
- saisonal malaria chimoprevention
-
Parakou, BeninAzizath MOUSSILIOU
Dec 25, 2022
Plasmodium Falciparum Infection Trial in Worldwide (Ferroquine SSR97193, Artefenomel, Placebo)
Terminated
- Plasmodium Falciparum Infection
- Ferroquine SSR97193
- +2 more
-
Cotonou, Benin
- +11 more
Mar 15, 2022
Plasmodium Falciparum Infection Trial in Worldwide (Artefenomel (OZ439), Ferroquine (SSR97193))
Completed
- Plasmodium Falciparum Infection
- Artefenomel (OZ439)
- Ferroquine (SSR97193)
-
Cotonou, Benin
- +6 more
Mar 10, 2022
Malaria,Falciparum, Malaria, Malaria Recrudescence Trial in Brisbane (Pyronaridine, P. falciparum IBSM infection)
Completed
- Malaria,Falciparum
- +5 more
- Pyronaridine
- P. falciparum IBSM infection
-
Brisbane, Queensland, Australia
- +1 more
Nov 3, 2022
Plasmodium Falciparum Infection Trial in Baltimore (NF54 P. falciparum malaria challenge)
Completed
- Plasmodium Falciparum Infection
- NF54 P. falciparum malaria challenge
-
Baltimore, MarylandUniversity of Maryland School of Medicine - Center for Vaccine D
Jun 3, 2021
Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome Trial in Brisbane (MMV367, P. falciparum IBSM
Recruiting
- Infections
- +11 more
- MMV367
- P. falciparum IBSM infection
-
Brisbane, Queensland, Australia
- +1 more
Jul 30, 2023